Sign up
Log in
GE HealthCare Recommends Shareholders Reject Mini-Tender Offer By Potemkin To Purchase Up To 100K Shares Of GE HealthCare Common Stock At $45.80/Shr In Cash
Share
Listen to the news

GE HealthCare Technologies Inc. (NASDAQ:GEHC) (the "Company" or "GE HealthCare") announced today that it received notice on March 30, 2026, of an unsolicited "mini-tender" offer by Potemkin Limited to purchase up to 100,000 shares of GE HealthCare common stock at a price of $45.80 per share in cash. Potemkin Limited's offer price of $45.80 per share is approximately 34.80 percent lower than the $70.25 closing per share price of GE HealthCare's common stock on March 18, 2026, the last trading day before the mini-tender offer appears to have commenced.

GE HealthCare does not endorse Potemkin Limited's unsolicited mini-tender offer and recommends that stockholders do not tender their shares in response to Potemkin Limited's offer because the offer is at a price that is significantly below the current market price for GE HealthCare's common stock and subject to numerous conditions. For example, under the terms of Potemkin Limited's offer, there could be a significant delay between the time that stockholders tender their shares and when stockholders will receive payment, and there are limits on the ability of tendering stockholders to withdraw their shares from the offer. GE HealthCare is not affiliated or associated in any way with Potemkin Limited, its mini-tender offer or its offer documentation, and GE HealthCare is not responsible for any obligations of the offer.

Potemkin Limited has made a similar mini-tender offer for shares of GE HealthCare common stock and for the shares of other companies. Mini-tender offers seek to acquire less than five percent of a company's outstanding shares, thereby avoiding many disclosure and procedural requirements of the U.S. Securities and Exchange Commission (the "SEC") that apply to offers of more than five percent of a company's outstanding shares. As a result, mini-tender offers do not provide investors with the same level of protections as provided for larger tender offers under U.S. securities laws.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.